» Authors » Dwight Oliver

Dwight Oliver

Explore the profile of Dwight Oliver including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 1586
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai L, Hammond N, Tasdogan A, Alsamraae M, Yang C, Cameron R, et al.
Cancer Discov . 2025 Feb; :OF1-OF15. PMID: 39960461
Intraoperative 13C-glucose infusions in patients with NSCLC show that tumors with high labeling of TCA cycle intermediates progress rapidly, resulting in metastasis and early death. Blocking this pathway suppresses metastasis...
2.
Garcia R, Alkayyali T, Gomez L, Wright C, Chen W, Oliver D, et al.
Cancer Genet . 2024 Nov; 288-289:92-105. PMID: 39499993
Objective: To illustrate patterns of cytogenetic abnormalities that promote progression and/or transformation in myelodysplastic syndrome. Methods: In this study we evaluated three different data sets to identify recurrent cytogenetic abnormalities...
3.
Miller S, Vandergriff T, Goff H, Xu J, Oliver D
Am J Dermatopathol . 2024 Mar; 46(9):581-587. PMID: 38457687
PCR-based fragment analysis of the T-cell receptor (TCR) gene is used extensively in diagnostic labs to assess clonality in T-cell populations in multiple tissue sites. Of the numerous TCR assays...
4.
Zhang C, Chu A, Boriack R, Collins R, Xu J, Oliver D, et al.
EJHaem . 2023 Aug; 4(3):723-727. PMID: 37601838
This study investigates whether serum D-2HG (D-2-hydroxyglutarate) produced by the mutated isocitrate dehydrogenase (IDH) can predict mutations in acute myeloid leukemia (AML) at diagnosis. D-2HG and L-2HG are measured by...
5.
Valencia J, Kaza V, Kim J, Oliver D, Vandergriff T, Wysocki C, et al.
JAAD Case Rep . 2023 Jun; 36:24-27. PMID: 37361400
No abstract available.
6.
Day A, Sample R, Salley J, Oliver D, Dahlstrom K, Sturgis E, et al.
Cancer Prev Res (Phila) . 2023 Jan; 16(3):127-132. PMID: 36596658
Prevention Relevance: Novel preventive interventions are needed to address the rising incidence of HPV+ OPC. In this feasibility study, we characterized barriers to a two-step, behavioral and biological screening program...
7.
Driskill J, Hwang H, Callan A, Oliver D
Case Rep Genet . 2022 Aug; 2022:9016497. PMID: 35967928
Fibro-adipose vascular anomaly (FAVA) is a recently described complex and painful benign lesion found in young adults and the pediatric population composed of intramuscular vascular, fibrous, and adipose tissues. A...
8.
Clark A, Wang Z, Ostman E, Zheng H, Yao H, Cantarel B, et al.
Clin Chem . 2022 May; 68(8):1042-1052. PMID: 35616102
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge, and effective tracking requires rapid return of results. Surveillance of variants is typically performed by whole genome sequencing...
9.
Brown T, Patel P, Oliver D, Churchill H, Monaghan S, Collins Jr R
JCO Precis Oncol . 2022 Feb; 3:1-6. PMID: 35100680
No abstract available.
10.
Xu J, Kirtek T, Xu Y, Zheng H, Yao H, Ostman E, et al.
Am J Clin Pathol . 2021 Apr; 155(6):815-822. PMID: 33822853
Objectives: The Bio-Rad SARS-CoV-2 ddPCR Kit (Bio-Rad Laboratories) was the first droplet digital polymerase chain reaction (ddPCR) assay to receive Food and Drug Administration (FDA) Emergency Use Authorization approval, but...